Agendia Achieves CE-IVDR Certification for its MammaPrint® and BluePrint® Breast Cancer AssaysContributed by: Business WireLogoTagsOncologyHealthOther ScienceResearchSciencePharmaceuticalBiotechnologyAgendia, Inc.